These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 18773839)
1. [Addictions and the workplace: what are the issues at stake for occupational health services?]. Durand E Sante Publique; 2008; 20 Suppl 3():S151-60. PubMed ID: 18773839 [TBL] [Abstract][Full Text] [Related]
2. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine. Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727 [TBL] [Abstract][Full Text] [Related]
3. [Preventing addictive practices in the workplace thanks to occupational health services]. Dano C Soins; 2017 Jun; 62(816):39-42. PubMed ID: 28648194 [TBL] [Abstract][Full Text] [Related]
4. Psychoactive drug consumption: performance-enhancing behaviour and pharmacodependence in workers. Ngoundo-Mbongue TB; Niezborala M; Sulem P; Briant-Vincens D; Bancarel Y; Jansou P; Chastan E; Montastruc JL; Lapeyre-Mestre M Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):81-9. PubMed ID: 15386725 [TBL] [Abstract][Full Text] [Related]
5. [Workplace and psychoactive substances dependence: certificate of eligibility for work and perspectives of prevention in the light of recent innovative regulations]. Spigno F; Debarbieri N; Traversa F G Ital Med Lav Ergon; 2007; 29(2):158-65. PubMed ID: 17886756 [TBL] [Abstract][Full Text] [Related]
6. [Professional drivers and psychoactive substances consumption: results from medical surveillance at the workplace in Piedmont region]. Rosso GL; Feola M; Rubinetto MP; Petti N; Rubinetto L G Ital Med Lav Ergon; 2011; 33(3 Suppl):203-6. PubMed ID: 23393836 [TBL] [Abstract][Full Text] [Related]
7. [Profile of psychoactive substances consumption in workplace]. Bœuf-Cazou O; Lapeyre-Mestre M; Niezborala M; Montastruc JL Therapie; 2011; 66(2):155-65. PubMed ID: 21635864 [TBL] [Abstract][Full Text] [Related]
8. [Legislation concerning alcohol and drug intake in the workplace]. Goszczyńiska E Med Pr; 2013; 64(4):593-608. PubMed ID: 24502123 [TBL] [Abstract][Full Text] [Related]
9. [Taking drugs in the working environment: a study in a sample of 2106 workers in the Toulouse metropolitan area]. Lapeyre-Mestre M; Sulem P; Niezborala M; Ngoundo-Mbongue TB; Briand-Vincens D; Jansou P; Bancarel Y; Chastan E; Montastruc JL Therapie; 2004; 59(6):615-23. PubMed ID: 15789825 [TBL] [Abstract][Full Text] [Related]
10. [Psychotropic medication use by French active self-employed workers]. Ha-Vinh P; Régnard P; Sauze L Presse Med; 2011 Apr; 40(4 Pt 1):e173-80. PubMed ID: 21227628 [TBL] [Abstract][Full Text] [Related]
11. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France. Pochard L; Dupouy J; Frauger E; Giocanti A; Micallef J; Lapeyre-Mestre M; Fundam Clin Pharmacol; 2018 Apr; 32(2):188-197. PubMed ID: 29337399 [TBL] [Abstract][Full Text] [Related]
12. [Psychoactive substance use during pregnancy: a review]. Lamy S; Thibaut F Encephale; 2010 Feb; 36(1):33-8. PubMed ID: 20159194 [TBL] [Abstract][Full Text] [Related]
13. Health educators in the workplace: helping companies respond to the AIDS crisis. Bauman LJ; Aberth J Health Educ Q; 1986; 13(4):395-406. PubMed ID: 3465714 [TBL] [Abstract][Full Text] [Related]
14. Testing for drugs of abuse in urine. Turk J Mo Med; 1989 Jun; 86(6):337-40. PubMed ID: 2755453 [TBL] [Abstract][Full Text] [Related]
15. AIDS control and the workplace: the role of occupational health services in South Africa. London L Int J Health Serv; 1998; 28(3):575-91. PubMed ID: 9711481 [TBL] [Abstract][Full Text] [Related]
16. The synergism of health promotion and restoration in the prevention of substance abuse in the workplace. Miller RE; Shain M; Crim D; Golaszewski TJ Health Values; 1985; 9(5):50-8. PubMed ID: 10317664 [TBL] [Abstract][Full Text] [Related]
17. [Workers with alcohol and drug addiction problems. Consensus Document of the Study Group on Hazardous Workers]. Magnavita N; Bergamaschi A; Chiarotti M; Colombi A; Deidda B; De Lorenzo G; Goggiamani A; Magnavita G; Ricciardi W; Sacco A; Spagnolo AG; Bevilacqua L; Brunati MM; Campanile T; Cappai M; Cicerone M; Ciprani F; Di Giannantonio M; Di Martino G; Fenudi L; Garbarino S; Lopez A; Mammi F; Orsini D; Ranalletta D; Simonazzi S; Stanzani C Med Lav; 2008; 99 Suppl 2():3-58. PubMed ID: 19248471 [TBL] [Abstract][Full Text] [Related]
18. [Psychoactive substance in the workplace]. Warnet S Rev Infirm; 2012 Mar; (179):8. PubMed ID: 22506364 [No Abstract] [Full Text] [Related]
19. Team awareness for workplace substance abuse prevention: the empirical and conceptual development of a training program. Bennett JB; Lehman WE; Reynolds GS Prev Sci; 2000 Sep; 1(3):157-72. PubMed ID: 11525346 [TBL] [Abstract][Full Text] [Related]
20. Administrative issues related to addiction in the workplace. Roberts S; Fallon LF Occup Med; 2001; 16(3):509-15, v. PubMed ID: 11401795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]